Cohorte Nationale VIH-2
ANRS CO VIH2
Cohorte ANRS CO5 "Cohorte Nationale VIH2"
1 other identifier
observational
1,185
1 country
29
Brief Summary
The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1994
Longer than P75 for all trials
29 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1994
CompletedFirst Submitted
Initial submission to the registry
August 5, 2020
CompletedFirst Posted
Study publicly available on registry
December 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedDecember 8, 2020
December 1, 2020
28.8 years
August 5, 2020
December 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Study HIV-2 infection rate in adult patients followed in France
At the baseline
Secondary Outcomes (6)
The clinical progression of patients infected HIV-2 evaluate by samples: biological examinations
Up to 25 years
The epidemiological parameters and progression of patients infected with HIV-2 evaluate by a questionnaire
Up to 25 years
The rate of immuno-virological charge of the infection evaluate by serology samples
Up to 25 years
Pourcentage of patient with HIV-2
Up to 25 years
Pourcentage of response to antiretroviral treatment evaluate by serology samples
Up to 25 years
- +1 more secondary outcomes
Interventions
Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection.
Eligibility Criteria
HIV-2 infection only followed in consultation or hospitalization in one of the participating centers in France
You may qualify if:
- HIV-2 infection only, diagnosed by ELISA, confirmed by Western-Blot test,
- Follow-up in consultation or hospitalization in one of the investigating centers,
- Age greater than or equal to 18 years,
- Prolonged follow-up possible, residence in France planned for at least one year,
- Consent to participate,
You may not qualify if:
- HIV-1 infection
- Double HIV-1 + HIV-2 seropositivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (29)
Centre hospitalier Victor Dupouy
Argenteuil, 95100, France
Avicenne
Bobigny, 93000, France
Hôpital Saint André
Bordeaux, 33076, France
Service de Medecine Interne Hopital Antoine Beclere
Clamart, 92140, France
Hôpital Louis Mourier
Colombes, 92700, France
Hôpital Sud Francilien
Corbeil-Essonnes, 91106, France
Hôpital Henri Mondor
Créteil, 94010, France
Service de Médecine interne - Centre Hospitalier Intercommunal
Créteil, 94010, France
Hôpital Edouard Herriot
Lyon, 69437, France
Hôpital de La Croix Rousse
Lyon, France
Centre Hospitalier François Quesnay
Mantes-la-Jolie, France
Hôpital Gui de Chaudiac
Montpellier, 34295, France
Hôpital de l'Hotel Dieu
Nantes, 44093, France
Hôpital Saint Louis
Paris, 75010, France
Hôpital Saint Antoine
Paris, 75012, France
Hôpital la Pitié Salpétrière
Paris, 75013, France
Service de Medecine Interne Hopital Cochin
Paris, 75014, France
Hôpital Bichat - Claude Bernard
Paris, 75018, France
Hôpital Tenon
Paris, 75020, France
Hôpital Hôtel Dieu
Paris, 75181, France
Hôpital Lariboisière
Paris, 75475, France
Hopital du Kremlin Bicêtre Service de médecine interne
Paris, 94275, France
Centre Hospitalier René Dubos
Pontoise, 95301, France
Hôpital Pontchaillou
Rennes, 35033, France
Hôpital Delafontaine
Saint-Denis, 93205, France
CHI Poissy Saint Germain en Laye
Saint-Germain-en-Laye, 78105, France
Hôpital Bretonneau - Service des Maladies Infectieuses
Tours, 37044, France
Hôpital André Mignot
Versailles, 78157, France
CHI Villeneuve Saint Georges
Villeneuve-Saint-Georges, 94195, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
François Dabis, Pr, MD
ANRS, Emerging Infectious Diseases
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2020
First Posted
December 8, 2020
Study Start
January 1, 1994
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
December 8, 2020
Record last verified: 2020-12